What is the recommended treatment for a urinary tract infection caused by Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Tract Infections Caused by Enterococcus faecalis

For uncomplicated urinary tract infections caused by Enterococcus faecalis, amoxicillin 500 mg orally every 8 hours for 7 days is the recommended first-line therapy. 1

First-Line Treatment Options

  • Amoxicillin 500 mg orally every 8 hours for 7 days is the first-line treatment for pansensitive E. faecalis UTIs, with high clinical (88.1%) and microbiological (86%) eradication rates 1, 2
  • Ampicillin 500 mg orally every 8 hours for 7 days is an equivalent alternative to amoxicillin with similar efficacy 1, 2
  • For inpatients requiring IV therapy, ampicillin 2 g IV every 4 hours is recommended 3

Alternative Treatment Options

  • Fosfomycin 3 g as a single oral dose is FDA-approved specifically for E. faecalis UTIs and offers convenient single-dose therapy 3, 2
  • Nitrofurantoin 100 mg orally every 6 hours for 7 days is an effective alternative with good in vitro activity against E. faecalis and low resistance rates 3, 1
  • For penicillin-allergic patients, nitrofurantoin or fosfomycin should be considered as first alternatives 1, 4

Treatment of Vancomycin-Resistant E. faecalis (VRE)

For VRE UTIs, the following options are recommended in order of preference:

  1. A single dose of fosfomycin 3 g PO for uncomplicated UTIs 3
  2. Nitrofurantoin 100 mg PO every 6 hours for uncomplicated UTIs 3
  3. High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg PO/IV every 8 hours for uncomplicated UTIs if susceptible 3
  4. Linezolid 600 mg IV or PO every 12 hours for complicated UTIs 3, 5

Important Considerations

  • Confirm susceptibility testing before initiating therapy, even for strains described as "pansensitive" 1, 2
  • Avoid fluoroquinolones due to high resistance rates (46-47% for ciprofloxacin/levofloxacin) and unfavorable risk-benefit profile for uncomplicated UTIs 2, 6
  • For beta-lactamase producing strains, consider replacing amoxicillin with amoxicillin-clavulanate for 7 days 1, 5
  • Differentiate between colonization and true infection to avoid unnecessary antibiotic use, particularly in catheterized patients 3, 7

Special Populations

  • For complicated UTIs or pyelonephritis, longer treatment durations may be necessary 1
  • For patients with hospital-acquired infections, prior healthcare center exposure, or treatment in urological departments, be aware of increased risk of fluoroquinolone resistance 6
  • For severe infections with bacteremia, consider high-dose daptomycin (8-12 mg/kg/day) for VRE strains 3

Treatment Algorithm

  1. Obtain urine culture and susceptibility testing
  2. For uncomplicated UTI with susceptible E. faecalis:
    • First choice: Amoxicillin or ampicillin 500 mg PO every 8 hours for 7 days 1, 2
    • Penicillin allergy: Nitrofurantoin 100 mg PO every 6 hours for 7 days or fosfomycin 3 g single dose 3, 1
  3. For VRE UTI:
    • Uncomplicated: Fosfomycin 3 g single dose or nitrofurantoin 100 mg PO every 6 hours 3
    • Complicated: Linezolid 600 mg PO/IV every 12 hours 3, 5

Remember that removal of urinary catheters should be considered when possible, as this may resolve the infection without antibiotics in catheter-associated UTIs 4.

References

Guideline

Treatment of Uncomplicated Enterococcus faecalis Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Best Oral Antibiotic for Uncomplicated Pansensitive Enterococcus faecalis UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.